6-Amino-5-Bromoquinoxaline CAS 50358-63-9 Puritas >99.0%

Description:

Nomen chemicum: 6-Amino-5-Bromoquinoxaline

Synonyma: V-Bromoquinoxalin-6-Amine

CAS: 50358-63-9

Puritas: >99.0% (HPLC)

Aspectus: Brown ad lucem luteum pulveris

Intermedia Brimonidine Tartrate (CAS: 70359-46-5)

Contactus: Dr

Mobile/Wechat/Whatsapp: +86-15026746401

E-Mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Descriptio:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of 6-Amino-5-Bromoquinoxaline (CAS: 50358-63-9) with high quality. We can provide COA, worldwide delivery, small and bulk quantities available. If you are interested in this product, please send detailed information includes CAS number, product name, quantity to us. Please contact: alvin@ruifuchem.com

Chemical Properties:

Nomen chemicum 6-Amino-5-Bromoquinoxaline
Synonyma 5-Bromoquinoxalin-6-Amine;5-Bromo-6-Quinoxalinamine;5-Bromo-6-Aminoquinoxaline
immunditia Brimonidine EP
CAS Number 50358-63-9
CATTUS Number RF2515
Stock Status In Stock, Productio Capacity 35 Tons per Month
Formulae hypotheticae C8H6BrN3
M. Pondus 224.06
Liquescens punctum 153.0 ad 157.0℃
Density 1.744±0.06 g/cm3
Brand Ruifu Chemical

Specifications:

Item Specifications
Aspectus Brown to Light-Clavus pulveris
Puritas / Analysis Methodus >99.0% (HPLC)
Liquescens punctum 153.0~157.0℃
Damnum in Siccatio <1.00%
Maximilianus.Individual Impurity <0.50%
Totalis immunditias <1.00%
Infrared Imaginis Conformat ut Structure
Proton NMR Spectrum Conformat ut Structure
Test Standard Enterprise Standard
Consuetudinem Intermedia Brimonidine Tartrate (CAS: 70359-46-5)

Liquescens punctum
Methodo probati generali utere et temperaturam auge 1.5℃/minute.Confluere inter 153.0~157.0℃
Damnum in Siccatio
Non plus quam 1.0% Intentus 1.0g siccando in clibano ad 105' usque ad pondus constans
Related composita (HPLC)
Systema chromatographicum:
Columna: ODS, C18;
Detector adsum: 264nm
Fluunt rate: 1.0 ml per minute
Mobile tempus:
Para saccata et degassata mixtum quiddam (solvo 2.6g Natrium 1-heptanesulfonatum in 690ml aquae) acidum triethylamine aceticum-methanolum-glacialem (690:310:7.5:2.5).
Sample solutio praeparationis:
Specimen accuratum ponderatum 25.0mg in 25ml tempore mobilis dissolve.
De modo procedendi:
Volumen 10 l solutionis sample injiciunt et chromatogrammata ad 4 tempora retentionis notare tempus summi culminis.Adice immunditiae cacumina vestis apicem minuunt.Summa
immunditia non plus quam 1.00%, immunditia quaevis individua non plus quam 0.50%.

Synthesis itineris de 6-Amino-5-Bromoquinoxaline (CAS: 50358-63-9)

www.ruifuchemical.com

Sarcina & Repono:

sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore

commoda:

Satis capacitas: sufficientes facilities et technici

Professional Service: One stop acquireing service

Altera Package: Custom sarcina ac titulus praesto

Ieiunium Delivery: Si intra stirpem, tres dies partus praestatur

Supple firmum: Esse rationabile stirpe

Technical Support: Technology solution praesto

Custom Synthesis Service: Range from P. to kilos

High Quality: Constitutus ratio completa qualitas certitudinis

FAQ:

Quam mercari?Please contact: sales@ruifuchem.com or alvin@ruifuchem.com 

15 Years Experience?Plus quam XV annos experientiae habemus in fabricando et exportando amplis intermediis pharmaceuticis vel alchimicis pharmaceuticis amplis.

Mercatus principalis?Vendere mercatum domesticum, Americam septentrionalem, Europam, Indiam, Russiam, Coream, Iaponicam, Australiam etc.

Commodi?Praeclara qualitas, parabilis pretium, professionalia officia et technicae firmamentum, ieiunium partus.

Qualitasfides?Qualitas strictioris temperantiae ratio.Pro instrumento analysi professionali includuntur NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Claritas, Solubilitas, Microbialis limes test, etc.

Exempla?Pleraque producta praebent exempla gratuita pro qualitate aestimationis, sumptus naviculas a clientibus solvendos.

Factory Audit?Factory audit gratissimum.Quaeso ante constitutum.

MOQ?Nec MOQ.Parvus ordo placet.

Tempus adferendi? Si intus prosapia, tres dies partus praestatur.

Transportatio?Per Express (FedEx, DHL), ab Air, per Mare.

Documenta?Post servitium venditionis: COA, MOA, ROS, MSDS, etc. praeberi possunt.

Consuetudo Synthesis?Consuetudo synthesis officia praebere potest ad optimas investigationes tuas necessitates aptandas.

Pensio conditio?Proforma cautionis primum post confirmationem ordinis mittetur, informationes nostrae ripae inclusas.Payment by T/T (Telex Transfer), PayPal, Western Union, etc.

Applicatio:

6-Amino-5-Bromoquinoxaline (CAS: 50358-63-9) medium est momenti derivatorum quinoxalinorum.6-Amino-5-Bromoquinoxaline pro media pharmaceutica, media Brimonidine Tartrate (CAS: 70359-46-5).Brimonidine est valde selectivum α-receptor obstructorem, feliciter elaboratum ab Allergan US Societatis, quod est medicamentum oculi.Potest pressionem intraocularem reducere (IOP).Brimonidinum solutionis ophthalmicae tartratae in foro venditio est forma brimonidine tartrata, quae bonum medicamentum IOP-demissione in glaucoma-angulo aperto et ocularibus hypertensione curationis aegrorum, sed etiam pro laseris argonis IOP aequat.Solutio brimonidorum tartratorum ophthalmicorum duplicem mechanismum actionis habet reducendo productionem humoris aquei et augendo in strato pigmenti liquoris scleralis fluxi therapeutici.Postquam in oculum distillant, effectus rapidus est, et ad apicem pervenire potest, cum usque ad 2h usus est, et tempus efficax 12h conservare potest.Sanguis tantum medicamentorum vestigia deprehendere potest.Productum hoc primum metabolismum in hepate habet, et metabolitae in urina a renibus redduntur.Effusio systemica et distributio affectus non sunt, et senes non egent commensuratione dosi.Brimonidinum solutio ophthalmicae tartratae cum aliis α-blockers comparata, parva pinguedo-solubilis est, dum non facile transit per impedimentum sanguinis-cerebri et sedationem, hypotensionem et alios similes motus contrarios centrales non producit.

Epistulam tuam hic scribe et mitte nobis